The Procter & Gamble Company

The Procter & Gamble Company Earnings Recaps

PG Consumer Defensive 4 recaps
Next earnings: January 28, 2027 (estimated) · full calendar
Q1 2027 Oct 24, 2026

P&G’s shares rose 5.6% after earnings, with investors responding to 4.0% organic sales growth, led by volume, and broad-based gains across categories and regions. The quarter also showed pressure underneath the top line: core operating margin fell 80 basis points as productivity was offset by higher commodity and freight costs and demand-creation investment.

Key takeaways
  • Organic sales increased 4.0%; volume contributed 2.4 points, pricing 0.4 points, and mix more than 1 point.
  • All 10 product categories and all six regions grew organic sales. North America was up 3%, Europe 4%, Greater China 8%, and IMEA 8%.
  • Core EPS was $2, up 1% year over year; on a currency-neutral basis, it was unchanged. Core gross margin declined 150 basis points.
  • Productivity improved 250 basis points, but higher commodity and freight costs and demand-creation investment weighed on margins. Management expects these cost headwinds to increase over the next few quarters while remaining within fiscal 2027 guidance ranges.
  • Free cash flow productivity was 93%; P&G returned $3.9 billion to shareholders through dividends and share repurchases.
Q4 2026 Jul 31, 2026

Shares of Procter & Gamble declined 3.3% following earnings as investors reacted negatively to lower core EPS and margin compression driven by cost pressures and trade dynamics, despite stable organic sales growth.

Key takeaways
  • Core EPS declined 3% year-over-year to $1.43 in Q4, with a 5% decrease on a currency-neutral basis.
  • Core operating margin contracted 130 basis points in the quarter, despite a 460 basis point productivity improvement.
  • Organic sales were essentially flat in Q4, with modest 1% growth adjusted for restructuring impacts and 2% growth excluding inventory timing effects.
  • U.S. organic sales fell 1% amid trade-related sell-in and sell-out mismatches and retailer inventory reductions following shifts like the Amazon Prime Day timing.
  • Gross margin remained roughly flat year-over-year, but significant input cost spikes in energy, transportation, and materials weighed on profitability.
Q2 2026 Jan 22, 2026

Procter & Gamble reported a challenging second quarter with organic sales growth primarily driven by international markets, but expects stronger performance in the latter half of the fiscal year due to strategic innovations and productivity improvements.

Key takeaways
  • Organic sales were flat year-over-year, with volume down 1% and pricing up 1%; 7 of 10 product categories maintained or increased sales.
  • Noteworthy growth from Greater China, with mid-teens sales increase in Pampers and significant share gains in the premium segment.
  • Core earnings per share matched the prior year at $1.88, with a robust $4.8 billion returned to shareholders through dividends and share repurchases.
  • Core gross margin decreased by 50 basis points; productivity improvements launched, contributing 270 basis points of enhancement.
  • Anticipated stronger second-half performance supported by enhanced consumer insights and innovation-driven marketing strategies across key markets.
Q4 2025 Aug 2, 2025

Procter & Gamble demonstrated solid resilience in fiscal year 2025, achieving a 2% organic sales growth and a 4% increase in core EPS amid challenging market conditions. Strategic leadership transitions position the company for continued growth.

Key takeaways
  • Organic sales grew 2% for FY25, driven evenly by volume and price/mix contributions, with nine of ten product categories experiencing growth.
  • Core EPS increased to $6.83, reflecting efficient cost management and a focus on productivity improvements despite a 40 basis point decline in core gross margin.
  • The company returned $16 billion to shareholders, including nearly $10 billion in dividends and $6.5 billion through share repurchases, remaining consistent with prior guidance.